In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...

We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...

A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA, which could help it to ...

This paper synthesizes recent evidence on refugee self-reliance in low- and middle-income countries, clarifying definitions, ...

Chronic subdural hematoma (cSDH) is frequently encountered in neurosurgical practice. Apart from traditional treatment approaches, such as surgical intervention or medical management, middle meningeal ...

Mucoceles are benign sinus tumors that are caused by an obstruction in the sinus ostium. We report 3cases managed at the University Hospital of Kamenge, where treatment was surgical via an endoscopic ...